Latin America, Middle East & Africa Smart Biopsy Market (2019-2025)
The Latin America, Middle East and Africa Smart Biopsy Market would witness market growth of 5.97% CAGR during the forecast period (2019-2025).
Ever-miniaturizing technology in medical imaging has given rise to certain new and exciting opportunities. In recent times, the medical industry has witnessed the development of a complex lens system that fits inside a syringe, an optical sensor that fits for precision guidance at the end of an epidural needle, and a camera-loaded catheter that streams live from inside arteries and even removes plaque simultaneously.
After scientists developed a new "smart needle" that uses a mini laser to identify diseased tissue within seconds, cancer detection would become much faster and easier in the future. Scientists have demonstrated the laboratory functions of the technique and have launched a major three-year clinical trial in 2019 to test it in people. They have so far focused on lymphoma but are hopeful that the technique can also be used to detect other forms of diseases such as breast and prostate cancer further down the line.
Apparently, lymphoma diagnosis can be an invasive process involving a surgical biopsy accompanied by a nerve-wracking wait for the result that can often take two weeks or more. The smart needle uses light to almost instantly identify cancerous tissues. Using a method called Raman spectroscopy, when a laser embedded in the needle reflects on it, the' optical biopsy' measures the light dispersed by tissues. The light is absorbed differently from healthy and diseased tissues, which ensures that doctors will immediately make a diagnosis.
Based on Application, the market is segmented into Breast cancer, Skin cancer, Liver cancer, Prostate cancer and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation, Argon Medical Devices, Inc., Cardinal Health, Inc., Canon, Inc. (Canon Medical Systems Corporation), Boston Scientific Corporation, Olympus Corporation, Hologic, Inc., B. Braun Melsungen AG, Cook Medical, Inc. (Cook Group) and Medtronic Plc.
Scope of the Study
Market Segmentation:
By Application
Ever-miniaturizing technology in medical imaging has given rise to certain new and exciting opportunities. In recent times, the medical industry has witnessed the development of a complex lens system that fits inside a syringe, an optical sensor that fits for precision guidance at the end of an epidural needle, and a camera-loaded catheter that streams live from inside arteries and even removes plaque simultaneously.
After scientists developed a new "smart needle" that uses a mini laser to identify diseased tissue within seconds, cancer detection would become much faster and easier in the future. Scientists have demonstrated the laboratory functions of the technique and have launched a major three-year clinical trial in 2019 to test it in people. They have so far focused on lymphoma but are hopeful that the technique can also be used to detect other forms of diseases such as breast and prostate cancer further down the line.
Apparently, lymphoma diagnosis can be an invasive process involving a surgical biopsy accompanied by a nerve-wracking wait for the result that can often take two weeks or more. The smart needle uses light to almost instantly identify cancerous tissues. Using a method called Raman spectroscopy, when a laser embedded in the needle reflects on it, the' optical biopsy' measures the light dispersed by tissues. The light is absorbed differently from healthy and diseased tissues, which ensures that doctors will immediately make a diagnosis.
Based on Application, the market is segmented into Breast cancer, Skin cancer, Liver cancer, Prostate cancer and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation, Argon Medical Devices, Inc., Cardinal Health, Inc., Canon, Inc. (Canon Medical Systems Corporation), Boston Scientific Corporation, Olympus Corporation, Hologic, Inc., B. Braun Melsungen AG, Cook Medical, Inc. (Cook Group) and Medtronic Plc.
Scope of the Study
Market Segmentation:
By Application
- Breast cancer
- Skin cancer
- Liver cancer
- Prostate cancer and
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Danaher Corporation
- Argon Medical Devices, Inc.
- Cardinal Health, Inc.
- Canon, Inc. (Canon Medical Systems Corporation)
- Boston Scientific Corporation
- Olympus Corporation
- Hologic, Inc.
- B. Braun Melsungen AG
- Cook Medical, Inc. (Cook Group)
- Medtronic Plc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Smart Biopsy Market, by Application
1.4.2 LAMEA Smart Biopsy Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. MARKET ANALYSIS
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches
3.2.3 Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Nov – 2016-May) Leading Players
CHAPTER 4. LAMEA SMART BIOPSY MARKET BY APPLICATION
4.1 LAMEA Breast cancer Market by Country
4.2 LAMEA Skin cancer Market by Country
4.3 LAMEA Liver cancer Market by Country
4.4 LAMEA Prostate cancer Market by Country
4.5 LAMEA Others Market by Country
CHAPTER 5. LAMEA SMART BIOPSY MARKET BY COUNTRY
5.1 Brazil Smart Biopsy Market
5.1.1 Brazil Smart Biopsy Market by Application
5.2 Argentina Smart Biopsy Market
5.2.1 Argentina Smart Biopsy Market by Application
5.3 UAE Smart Biopsy Market
5.3.1 UAE Smart Biopsy Market by Application
5.4 Saudi Arabia Smart Biopsy Market
5.4.1 Saudi Arabia Smart Biopsy Market by Application
5.5 South Africa Smart Biopsy Market
5.5.1 South Africa Smart Biopsy Market by Application
5.6 Nigeria Smart Biopsy Market
5.6.1 Nigeria Smart Biopsy Market by Application
5.7 Rest of LAMEA Smart Biopsy Market
5.7.1 Rest of LAMEA Smart Biopsy Market by Application
CHAPTER 6. COMPANY PROFILES
6.1 Danaher Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches:
6.1.5.2 Acquisition and Mergers:
6.1.6 SWOT Analysis
6.2 Argon Medical Devices, Inc.
6.2.1 Company Overview
6.2.1 Recent strategies and developments:
6.2.1.1 Partnerships, Collaborations, and Agreements:
6.2.1.2 Acquisition and Mergers:
6.3 Cardinal Health, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Recent strategies and developments:
6.3.4.1 Acquisition and Mergers:
6.4 Canon, Inc. (Canon Medical Systems Corporation)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Product Launches:
6.4.5.2 Acquisition and Mergers:
6.4.5.3 Expansions:
6.4.6 SWOT Analysis
6.5 Boston Scientific Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Product Launches:
6.5.5.2 Acquisition and Mergers:
6.5.5.3 Expansions:
6.5.6 SWOT Analysis
6.6 Olympus Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.6.5.2 Acquisition and Mergers:
6.7 Hologic, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Product Launches:
6.7.5.2 Partnerships, Collaborations, and Agreements:
6.7.5.3 Acquisition and Mergers:
6.7.6 SWOT Analysis
6.8 B. Braun Melsungen AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Cook Medical, Inc. (Cook Group)
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Product Launches:
6.1 Medtronic PLC
6.10.1 Company overview
6.10.2 Financial Analysis
6.10.3 Segmental and Regional Analysis
6.10.4 Research & Development Expenses
6.10.5 Recent strategies and developments:
6.10.5.1 Product Launches:
6.10.5.2 Acquisition and Mergers:
6.10.6 SWOT Analysis
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Smart Biopsy Market, by Application
1.4.2 LAMEA Smart Biopsy Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. MARKET ANALYSIS
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches
3.2.3 Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Nov – 2016-May) Leading Players
CHAPTER 4. LAMEA SMART BIOPSY MARKET BY APPLICATION
4.1 LAMEA Breast cancer Market by Country
4.2 LAMEA Skin cancer Market by Country
4.3 LAMEA Liver cancer Market by Country
4.4 LAMEA Prostate cancer Market by Country
4.5 LAMEA Others Market by Country
CHAPTER 5. LAMEA SMART BIOPSY MARKET BY COUNTRY
5.1 Brazil Smart Biopsy Market
5.1.1 Brazil Smart Biopsy Market by Application
5.2 Argentina Smart Biopsy Market
5.2.1 Argentina Smart Biopsy Market by Application
5.3 UAE Smart Biopsy Market
5.3.1 UAE Smart Biopsy Market by Application
5.4 Saudi Arabia Smart Biopsy Market
5.4.1 Saudi Arabia Smart Biopsy Market by Application
5.5 South Africa Smart Biopsy Market
5.5.1 South Africa Smart Biopsy Market by Application
5.6 Nigeria Smart Biopsy Market
5.6.1 Nigeria Smart Biopsy Market by Application
5.7 Rest of LAMEA Smart Biopsy Market
5.7.1 Rest of LAMEA Smart Biopsy Market by Application
CHAPTER 6. COMPANY PROFILES
6.1 Danaher Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches:
6.1.5.2 Acquisition and Mergers:
6.1.6 SWOT Analysis
6.2 Argon Medical Devices, Inc.
6.2.1 Company Overview
6.2.1 Recent strategies and developments:
6.2.1.1 Partnerships, Collaborations, and Agreements:
6.2.1.2 Acquisition and Mergers:
6.3 Cardinal Health, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Recent strategies and developments:
6.3.4.1 Acquisition and Mergers:
6.4 Canon, Inc. (Canon Medical Systems Corporation)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Product Launches:
6.4.5.2 Acquisition and Mergers:
6.4.5.3 Expansions:
6.4.6 SWOT Analysis
6.5 Boston Scientific Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Product Launches:
6.5.5.2 Acquisition and Mergers:
6.5.5.3 Expansions:
6.5.6 SWOT Analysis
6.6 Olympus Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.6.5.2 Acquisition and Mergers:
6.7 Hologic, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Product Launches:
6.7.5.2 Partnerships, Collaborations, and Agreements:
6.7.5.3 Acquisition and Mergers:
6.7.6 SWOT Analysis
6.8 B. Braun Melsungen AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Cook Medical, Inc. (Cook Group)
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Product Launches:
6.1 Medtronic PLC
6.10.1 Company overview
6.10.2 Financial Analysis
6.10.3 Segmental and Regional Analysis
6.10.4 Research & Development Expenses
6.10.5 Recent strategies and developments:
6.10.5.1 Product Launches:
6.10.5.2 Acquisition and Mergers:
6.10.6 SWOT Analysis
LIST OF TABLES
TABLE 1 LAMEA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 2 LAMEA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– SMART BIOPSY DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES– SMART BIOPSY DEVICES MARKET
TABLE 5 EXPANSIONS– SMART BIOPSY DEVICES MARKET
TABLE 6 MERGERS & ACQUISITIONS – SMART BIOPSY DEVICES MARKET
TABLE 7 LAMEA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 8 LAMEA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 9 LAMEA BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 LAMEA BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 LAMEA SKIN CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 LAMEA SKIN CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 LAMEA LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 LAMEA LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 LAMEA PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 LAMEA PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 LAMEA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 LAMEA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 LAMEA SMART BIOPSY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 LAMEA SMART BIOPSY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 BRAZIL SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 22 BRAZIL SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 23 BRAZIL SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 24 BRAZIL SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 25 ARGENTINA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 26 ARGENTINA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 27 ARGENTINA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 28 ARGENTINA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 29 UAE SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 30 UAE SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 31 UAE SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 32 UAE SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 33 SAUDI ARABIA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 34 SAUDI ARABIA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 35 SAUDI ARABIA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 36 SAUDI ARABIA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 37 SOUTH AFRICA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 38 SOUTH AFRICA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 39 SOUTH AFRICA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 40 SOUTH AFRICA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 41 NIGERIA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 42 NIGERIA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 43 NIGERIA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 44 NIGERIA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 45 REST OF LAMEA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 46 REST OF LAMEA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 47 REST OF LAMEA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 48 REST OF LAMEA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 49 KEY INFORMATION – DANAHER CORPORATION
TABLE 50 KEY INFORMATION – ARGON MEDICAL DEVICES, INC.
TABLE 51 KEY INFORMATION – CARDINAL HEALTH, INC.
TABLE 52 KEY INFORMATION – CANON, INC.
TABLE 53 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 54 KEY INFORMATION – OLYMPUS CORPORATION
TABLE 55 KEY INFORMATION – HOLOGIC, INC.
TABLE 56 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 57 KEY INFORMATION – COOK MEDICAL, INC.
TABLE 58 KEY INFORMATION – MEDTRONIC PLC
TABLE 1 LAMEA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 2 LAMEA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– SMART BIOPSY DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES– SMART BIOPSY DEVICES MARKET
TABLE 5 EXPANSIONS– SMART BIOPSY DEVICES MARKET
TABLE 6 MERGERS & ACQUISITIONS – SMART BIOPSY DEVICES MARKET
TABLE 7 LAMEA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 8 LAMEA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 9 LAMEA BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 LAMEA BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 LAMEA SKIN CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 LAMEA SKIN CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 LAMEA LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 LAMEA LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 LAMEA PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 LAMEA PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 LAMEA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 LAMEA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 LAMEA SMART BIOPSY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 LAMEA SMART BIOPSY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 BRAZIL SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 22 BRAZIL SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 23 BRAZIL SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 24 BRAZIL SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 25 ARGENTINA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 26 ARGENTINA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 27 ARGENTINA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 28 ARGENTINA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 29 UAE SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 30 UAE SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 31 UAE SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 32 UAE SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 33 SAUDI ARABIA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 34 SAUDI ARABIA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 35 SAUDI ARABIA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 36 SAUDI ARABIA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 37 SOUTH AFRICA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 38 SOUTH AFRICA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 39 SOUTH AFRICA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 40 SOUTH AFRICA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 41 NIGERIA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 42 NIGERIA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 43 NIGERIA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 44 NIGERIA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 45 REST OF LAMEA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 46 REST OF LAMEA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 47 REST OF LAMEA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 48 REST OF LAMEA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 49 KEY INFORMATION – DANAHER CORPORATION
TABLE 50 KEY INFORMATION – ARGON MEDICAL DEVICES, INC.
TABLE 51 KEY INFORMATION – CARDINAL HEALTH, INC.
TABLE 52 KEY INFORMATION – CANON, INC.
TABLE 53 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 54 KEY INFORMATION – OLYMPUS CORPORATION
TABLE 55 KEY INFORMATION – HOLOGIC, INC.
TABLE 56 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 57 KEY INFORMATION – COOK MEDICAL, INC.
TABLE 58 KEY INFORMATION – MEDTRONIC PLC
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-NOV – 2016-MAY) LEADING PLAYERS
FIG 5 SWOT ANALYSIS: DANAHER CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: CANON, INC. (CANON MEDICAL SYSTEMS CORPORATION)
FIG 7 SWOT ANALYSIS: CANON, INC.
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 9 SWOT ANALYSIS: BOSTON SCIENTIFIC CORPORATION
FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: OLYMPUS CORPORATION
FIG 11 RECENT STRATEGIES AND DEVELOPMENTS: HOLOGIC, INC.
FIG 12 SWOT ANALYSIS: HOLOGIC, INC.
FIG 13 SWOT ANALYSIS: MEDTRONIC PLC
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-NOV – 2016-MAY) LEADING PLAYERS
FIG 5 SWOT ANALYSIS: DANAHER CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: CANON, INC. (CANON MEDICAL SYSTEMS CORPORATION)
FIG 7 SWOT ANALYSIS: CANON, INC.
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 9 SWOT ANALYSIS: BOSTON SCIENTIFIC CORPORATION
FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: OLYMPUS CORPORATION
FIG 11 RECENT STRATEGIES AND DEVELOPMENTS: HOLOGIC, INC.
FIG 12 SWOT ANALYSIS: HOLOGIC, INC.
FIG 13 SWOT ANALYSIS: MEDTRONIC PLC
